For decades, Americans have eaten thousands of ingredients they probably never think about.
Preservatives. Stabilizers. Flavoring agents. Emulsifiers. Sweeteners. Processing aids. Ingredients with names most shoppers would struggle to pronounce — yet many are perfectly legal to use in food.
But here is the part that surprises many people:
Under the current U.S. system, a company can sometimes determine for itself that a substance is “Generally Recognized as Safe,” or GRAS, and it has not always been required to notify the FDA before using that substance in food.
That system may now be heading for one of its biggest changes in decades.
In August 2026, the FDA proposed a rule that would make GRAS notifications mandatory for certain uses of substances in human and animal food, replacing much of today’s voluntary notification structure.
Supporters of reform describe this as an effort to close what critics often call the “GRAS loophole.”
But what exactly is GRAS?
Does it mean companies have been secretly putting unsafe chemicals into food?
And would the FDA’s proposal actually change what appears on supermarket shelves?
The reality is more nuanced — but potentially very important.
First, What Does GRAS Actually Mean?
GRAS stands for:
Generally Recognized as Safe.
Under U.S. food law, substances intentionally added to food are generally considered food additives and are subject to FDA premarket approval unless an exception applies.
One important exception is GRAS.
For a use of an ingredient to qualify as GRAS, its safety must be generally recognized among qualified experts and supported by adequate scientific evidence under the intended conditions of use. FDA says GRAS substances are expected to meet the same fundamental safety standard applied to approved food additives: a reasonable certainty of no harm when used as intended.
That means GRAS does not legally mean:
“Anything a company wants to add to food is automatically safe.”
The controversy revolves around who makes the initial safety determination — and whether FDA must be told about it.
Why Do Critics Call It a “Loophole”?
The word “loophole” is a criticism of the regulatory structure, not the official name of the program.
Under the existing system, a manufacturer may conclude that a particular use of a substance qualifies as GRAS.
The company can voluntarily submit a GRAS notice to FDA, providing scientific evidence and information supporting that conclusion.
But notification has not been mandatory.
FDA itself states that under the current voluntary program, companies may introduce a substance they consider GRAS without first notifying the agency or obtaining FDA review of that conclusion.
That is the feature reform advocates object to most.
Their concern is simple:
How can regulators fully monitor the food supply if they do not necessarily know every substance companies are introducing under a GRAS determination?
The food industry and other stakeholders, meanwhile, have pointed out that manufacturers remain legally responsible for ensuring that food is safe and that GRAS conclusions must satisfy statutory safety requirements.
So the dispute is not whether companies have safety obligations.
It is whether voluntary disclosure provides enough transparency and oversight.
What Is the FDA Proposing in 2026?
On August 10, 2026, HHS announced a proposed FDA rule designed to fundamentally change how GRAS determinations are reported.
Under the proposal, companies would generally have to submit GRAS notices to FDA for certain substances they intend to introduce into interstate commerce under the GRAS framework.
In practical terms, the system would shift from:
“You may notify FDA.”
toward:
“For covered uses, you must notify FDA.”
The proposed rule would also require FDA to maintain public-facing information about mandatory GRAS notices and would clarify procedures for determining when a substance does not qualify as GRAS.
That may sound like a bureaucratic technicality.
It is not.
It could significantly increase FDA’s visibility into which substances are entering the food supply.
Would FDA Have to Approve Every Ingredient Before It Is Used?
Not exactly.
This distinction matters.
The proposal does not simply eliminate the GRAS category or transform every GRAS ingredient into a conventional food additive requiring the same kind of premarket approval.
A substance that legitimately qualifies as GRAS remains legally distinct from a food additive requiring formal FDA approval.
Instead, the proposal focuses heavily on mandatory notification, transparency, documentation, and FDA awareness.
FDA says the change would help the agency determine more efficiently whether a substance truly qualifies for the GRAS exemption or should instead be treated as a food additive subject to premarket review.
So the proposal is better understood as a major oversight reform than as a blanket new approval system.
What Would Companies Have to Reveal?
The current GRAS notification system already allows companies to submit substantial supporting information.
FDA’s public GRAS inventory can include information such as:
the identity of the substance,
the manufacturer or notifier,
the intended conditions of use,
the scientific basis for the GRAS conclusion,
the date FDA received the notice,
and FDA’s response.
If notification becomes mandatory for covered substances, far more GRAS conclusions could potentially enter this transparent public system.
That means researchers, physicians, consumer groups, competing companies, journalists, and ordinary consumers could have greater visibility into ingredients entering the marketplace.
Transparency may ultimately be one of the proposal’s most consequential effects.
Does “FDA Has No Questions” Mean FDA Approved the Ingredient?
Not necessarily.
This is another area where food regulation is often misunderstood.
When FDA reviews a voluntarily submitted GRAS notice, its response may state that the agency has “no questions” regarding the notifier’s GRAS conclusion.
FDA maintains a searchable database containing GRAS notices and its response letters.
But a “no questions” letter is not identical to FDA formally approving the ingredient as a food additive.
The legal basis remains the GRAS conclusion under the conditions described.
That distinction may sound minor, but it is central to understanding how the system works.
Why Is This Happening Now?
The proposed change is part of a broader 2026 federal push to rethink food chemical oversight.
FDA’s Human Foods Program listed GRAS reform among its priority initiatives and also announced expanded post-market reviews of chemicals already used in food.
Among substances the agency has identified for evaluation are phthalates, propylparaben, BHA, BHT, and other chemicals.
The FDA has also created a more systematic process for reviewing chemicals after they are already on the market.
That process includes:
signal identification, prioritization, scientific assessment, and risk management.
This signals a broader shift.
Instead of focusing only on new ingredients before they enter commerce, regulators are placing more emphasis on periodically reassessing substances already present in the food supply as new scientific evidence emerges.
Does This Mean GRAS Ingredients Are Unsafe?
No.
The existence of the GRAS system should not be interpreted as evidence that GRAS ingredients are inherently dangerous.
Many familiar food substances can qualify as GRAS.
FDA gives examples including vinegar, canola oil, and spices such as black pepper.
The concern is therefore not:
“GRAS equals dangerous.”
The concern is:
“Should companies be able to make certain GRAS determinations without automatically informing regulators?”
Those are very different questions.
An ingredient’s safety ultimately depends on factors such as:
dose,
exposure,
purity,
how it is manufactured,
which foods it appears in,
how often people consume it,
and what scientific evidence exists.
Simply calling an ingredient “natural,” “chemical,” or “GRAS” tells us very little about its actual risk by itself.
What About Ingredients Already on the Market?
This may become one of the most important parts of the rule.
FDA’s proposal includes provisions dealing with substances already being used in interstate commerce, including a time-limited streamlined submission pathway for certain existing uses.
That matters because the U.S. food supply did not begin yesterday.
Thousands of ingredients and uses have accumulated through decades of changing manufacturing practices.
Any major regulatory reform therefore has to address two separate questions:
What happens to new substances entering food?
And what happens to existing substances already being sold?
Exactly how those transitional rules operate will depend on the final regulation.
Could Ingredients Be Removed From Food?
Potentially — but not simply because a GRAS notice becomes mandatory.
FDA already has authority to act when a substance does not meet applicable legal safety requirements.
The agency can evaluate new scientific evidence and determine that a particular use does not qualify as GRAS.
If a substance is neither GRAS nor otherwise legally authorized as a food additive, food containing it may be considered adulterated under federal law.
The new notification system could make it easier for FDA to identify questionable GRAS conclusions because the agency would receive more information about substances companies are actually using.
In other words, the reform could make hidden regulatory blind spots smaller.
But it would not automatically ban thousands of ingredients overnight.
Why Consumers Should Pay Attention
Most shoppers do not read regulatory filings.
They look at ingredient labels.
And even then, many assume that if something is legally sold in food, the FDA must have individually evaluated and approved it before it reached the market.
That assumption is not always accurate.
The U.S. food system contains several different regulatory pathways, and GRAS has historically allowed qualifying substances to avoid conventional food-additive premarket approval.
The proposed rule would not erase those distinctions.
But it could make the process far more visible.
That could have significant consequences for consumer confidence.
Industry Could Feel the Change Too
Greater oversight comes with costs.
FDA’s regulatory impact analysis estimates that companies would face expenses associated with preparing notices, updating procedures, and complying with the new requirements.
The agency estimated annualized costs in the range of roughly $10–12 million under its central assumptions, with considerable uncertainty around the estimate.
Companies may argue that expanded reporting creates paperwork, delays innovation, or increases costs.
Supporters may respond that transparency and independent regulatory visibility are worthwhile when substances are being consumed by millions of people.
Those competing considerations will likely shape the public-comment process.
So, Is the “GRAS Loophole” Finally Closing?
Possibly — but the change is not final yet.
As of September 2026, FDA has proposed the rule and is gathering public feedback.
The existing system has not simply disappeared.
If the proposal is finalized substantially as written, mandatory notification would represent one of the largest changes to federal GRAS oversight in years.
The most important change may be remarkably simple:
FDA would know far more about what companies are putting into food under GRAS claims.
That does not mean every unfamiliar ingredient is dangerous.
It does not mean every company has abused the existing system.
And it does not mean government review can eliminate every food-safety risk.
But when millions of people consume the same substances every day, one principle is difficult to argue against:
The evidence supporting their safety should be clear, scientifically defensible, and visible to the regulators responsible for protecting the food supply.
The next question is whether the final rule will deliver that level of transparency — and how much the American food industry will change as a result.
